Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 115

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 115
---
 under our 2024 ONSG PSPs, please see Long-Term Incentives and Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table — 2024 ONSG on pages 62 and 78 , respectively.

#### 2025 Proxy Statement95

#### Executive Compensation
If a NEO’s employment was terminated without Cause or if the NEO resigned for Good Reason following a change in control on December 31, 2024, (a) the awards under our 2023 rTSR PSP would accelerate, subject to proration as described in the foregoing paragraph, at 200% of target because the Company’s rTSR performance during the period beginning January 1, 2023 to December 31, 2024 ranked 95 th compare d to its 62 peers for that period, and (b) the awards under our 2024 rTSR PSP would be forfeited because the change in control did not occur after December 31 in the year of grant. Because we have not yet reached the end of the Performance Period for the awards under the 2023 and 2024 rTSR PSPs, we are unable to ascertain with certainty the value of the TSR performance-based RSUs that the NEOs would be entitled to in the event of retirement, death or disability on December 31, 2024. In such events, assuming that the Company’s performance at the end of the Performance Period is the same as for the one- and two-year periods ended December 31, 2024, (a) the awards under our 2023 rTSR PSP would accelerate, subject to proration as described in the foregoing paragrap h, at 200% o f target, and (b) the awards under our 2024 rTSR PSP would accelerate, subject to proration as described in the foregoing paragraph, at 200% of target because the Company’s rTSR performance during the period beginning January 1, 2024 and ended December 31, 2024 ranked 98 th percentile relative t o that of the other companies in the S&P 500 Health Care Index for that period.

For a discussion of the actual performance under our 2022, 2023 and 2024 rTSR PSPs, please see the footnotes to the Outstanding Equity Awards At Fiscal Year End Table beginning on page 82 .

If a NEO’s employment was terminated without Cause or if the NEO resigned for Good Reason following a change in